Literature DB >> 30325820

18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.

Emine Acar, Gamze Çapa Kaya1.   

Abstract

Prostate large cell neuroendocrine tumor is a rare disease. In this case, metastatic areas showing FDG uptake, somatostatin receptor positivity, and PSMA expression are shown in F-FDG PET/CT, Ga-DOTATATE PET/CT, and Ga-PSMA PET/CT in a 70-year-old man with the diagnosis of prostate large cell neuroendocrine carcinoma.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30325820     DOI： 10.1097/RLU.0000000000002322

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  4 in total

1.  Obstructive Jaundice: An Unusual Presentation of Neuroendocrine Differentiation in Prostatic Adenocarcinoma.

Authors:  Sampath Santhosh; Godwin Jeeva; Ranjan Kumar Mohapatra
Journal:  Indian J Nucl Med       Date:  2021-03-04

2.  Analysis of the Diagnostic Efficacy of DOTATATE Imaging Combined with CGA and BSP Detection Mode for NEN Patients with Bone Metastasis.

Authors:  Lei Lei; Tao Du; Jianbo Yang; Liang Cai; Huipan Liu; Yue Chen
Journal:  Biomed Res Int       Date:  2022-07-23       Impact factor: 3.246

3.  Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation.

Authors:  Marco Bergamini; Alberto Dalla Volta; Irene Caramella; Luisa Bercich; Simona Fisogni; Mattia Bertoli; Francesca Valcamonico; Salvatore Grisanti; Pietro Luigi Poliani; Francesco Bertagna; Alfredo Berruti
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

4.  Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake.

Authors:  Matteo Bauckneht; Silvia Morbelli; Alberto Miceli; Sara Elena Rebuzzi; Giuseppe Fornarini
Journal:  Diagnostics (Basel)       Date:  2021-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.